New rapid antigenic swab COVID-19

"We are continuing to double our production of rapid Corona tests, because we want to help contain the pandemic," says Roland Meißner, CEO of nal von minden GmbH. Demand for the NADAL® Covid-19 antigen test is very high. For this reason, already in November the monthly production was increased from 20 million rapid tests to 40 million. Now production capacities are further expanding rapidly. The new goal: to make 80 million rapid Corona tests available per month starting in January. “Possibly infected people can be detected immediately with the help of rapid tests and thus other people can be better protected against Corona,” emphasizes Meißner.
Even if the first vaccines are on the way and new hope is emerging to finally put an end to the pandemic, it will certainly take some time before all or most people are vaccinated. "Rapid tests continue to play a very important role, especially for the protection of risk groups such as people in need of treatment," says Meißner. Rapid tests are therefore mainly delivered to healthcare professionals such as geriatric nurses or doctors.
The NADAL® Covid-19 antigen test is performed on site and does not need to be sent to the laboratory. The result is available in just 15 minutes. For the test, a swab is taken from the mouth or nasopharynx by a professional doctor.
The quality of the NADAL® Covid-19 antigen test has been tested several times. Meißner: "The diagnostic specificity is above 99.9%, the diagnostic sensitivity is 97.56%." Specificity provides information on whether all healthy people tested are recognized as such. Sensitivity indicates whether all sick people are recognized as such.

[SOURCE ANSA.IT]